Neuphoria Therapeutics In... (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

5.00

-0.07 (-1.38%)

At close: May 01, 2025, 3:59 PM

5.00

0.00%

Pre-market: May 02, 2025, 08:21 AM EDT

Neuphoria Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Cash & Equivalents	12.61M	12.1M	23.09M	21.41M	3.15M	9.79M	18.31M	32.95M
Short-Term Investments	n/a	n/a	n/a	327.31K	n/a	385.19K	404.02K	422.65K
Long-Term Investments	n/a	n/a	n/a	119K	436.17K	384K	282.08K	295.08K
Other Long-Term Assets	78.83K	78.9K	81.86K	-29.59K	-136.47K	-115.07K	n/a	2.00
Receivables	126.88K	426.09K	4.67M	849.85K	40.74K	621.02K	523.5K	7.6M
Inventory	n/a	n/a	1.00	2.00	1.00	465.4K	360.02K	327.16K
Other Current Assets	n/a	n/a	-0.00	327.31K	2.01M	5.49M	6.09M	2.02K
Total Current Assets	13.19M	13.33M	28.76M	23.24M	5.73M	17.6M	26.39M	41.86M
Property-Plant & Equipment	218.97K	333K	464.01K	654.37K	724.9K	1.76M	2.02M	2.01M
Goodwill & Intangibles	14.16M	14.82M	15.62M	16.79M	16.93M	17.95M	19.11M	20.44M
Total Long-Term Assets	14.46M	15.24M	16.17M	17.53M	17.95M	19.98M	21.41M	22.74M
Total Assets	27.65M	28.56M	44.93M	40.77M	23.68M	37.58M	47.8M	64.61M
Account Payables	2.24M	1.44M	1.07M	772.93K	866.78K	842.3K	2.65M	1.46M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	158.09K	64.17K	14.99K
Short-Term Debt	33.12K	n/a	n/a	n/a	3.56M	5.92M	4.29M	6.53M
Other Current Liabilities	328.88K	72.56K	281.57K	279.45K	267.17K	654.1K	1.1M	1.31M
Total Current Liabilities	3.83M	2.74M	2.31M	1.77M	5.68M	9.67M	9.76M	10.67M
Long-Term Debt	n/a	n/a	n/a	n/a	4.3M	6.06M	11.56M	7.69M
Other Long-Term Liabilities	5.25M	2.47M	1.86M	1.33M	3.45M	7.4M	11.81M	11.49M
Total Long-Term Liabilities	6.33M	3.81M	3.47M	3.23M	9.28M	15.52M	25.58M	22.85M
Total Liabilities	10.16M	6.55M	5.78M	5.01M	14.97M	25.18M	35.34M	33.52M
Total Debt	272.74K	353.76K	477.15K	652.04K	8.41M	11.98M	15.85M	14.22M
Common Stock	n/a	n/a	149.75M	142.9M	101.8M	101.51M	99.33M	103.38M
Retained Earnings	-177.98M	-162.48M	-119.22M	-115.74M	-102.3M	-98.65M	-96.49M	-83.14M
Comprehensive Income	-3.01M	-3.06M	8.62M	8.6M	9.22M	9.54M	9.62M	10.85M
Shareholders Equity	17.49M	22.01M	39.15M	35.76M	8.71M	12.39M	12.46M	31.09M
Total Investments	n/a	n/a	n/a	446.31K	436.17K	769.19K	686.11K	717.73K